Blog Profile / Pharmalot
| URL : | http://www.pharmalot.com/ | |
|---|---|---|
| Filed Under: | Medical / Pharmaceutical | |
| Posts on Regator: | 4970 | |
| Posts / Week: | 20.7 | |
| Archived Since: | November 10, 2008 | |
Blog Post Archive
ADA's Ratner: We Expect Patient Level Data From All Drugmakers
Last week, the NIH ran a workshop to examine the safety of several widely used diabetes drugs called GLP-1 inhibitors and whether a definitive link can be established to acute pancreatitis and pancreatic cancer, which were the subject of recent studies that generated considerable controversy. Show More Summary
FDA Investigates Two Deaths In Zyprexa Patients
Here is a mystery that will be closely tracked. The FDA is probing the unexplained deaths of two people who were injected with long-acting Zyprexa, the antipsychotic, which is sold by Eli Lilly. Each died three to four days after receiving...Show More Summary
Is It Time To Overhaul The FDA? A Panel With Pharmalot
Is the FDA doing the right job? Some critics argue the agency fails to move fast enough to approve new drugs and still others maintain some decisions may be compromised by industry user fees or ties held by advisory panel members who made important recommendations. Show More Summary
Spinal Tap: Reviews Question Benefit Of Medtronic Spinal Product
As the result of an unusual effort designed to bolster transparency in clinical trials, two independent analyses have found that a Medtronic product used as a bone graft substitute in spinal fusion surgeries offers little benefit over...Show More Summary
Pharmalot... Pharmalittle... Good Morning
Top of the morning to you. A shiny day is unfolding here on the Pharmalot corporate campus, where are the birds are chirping, the official mascots are fertilizing the assorted weeds and short people are hustling off to their final rounds of learning at the schoolhouses. Show More Summary
Supreme Court Rules Drugmakers Can Be Sued For Pay-To-Delay Deals
After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over so-called pay-to-delay patent settlements, but that such deals should not necessarily be assumed to be illegal.
In...Show More Summary
READER POLL: Should Diabetes Drugmakers Provide Patient-Level Data?
Last week, the NIH ran a workshop to examine the safety of several widely used diabetes drugs and whether a definitive link can be established to acute pancreatitis and pancreatic cancer, which were the subject of recent studies that have generated considerable controversy. Show More Summary
Citing Side Effects, Japan Pulls Recommendations For HPV Vaccines
In the latest blow to drugmakers that market HPV vaccines, the Japanese health ministry has withdrawn its recommendation for vaccination after receiving hundreds of side effects reports of long-term pain and numbness, among other things, The Asahi Shimbun writes. Show More Summary
Pharmalot... Pharmalittle... Good Morning
Welcome to the working week. We hope the weekend respite was relaxing and provided an opportunity to enjoy life a wee bit. Now, though, that familiar routine of meetings and deadlines has returned. Summer may be edging closer, but this is likely to be a busy week. Show More Summary
New Merck R&D Chief Overhauls Operations & Cuts Are Coming
Two months after arriving at Merck as the new head of R&D, Roger Perlmutter is moving quickly to overhaul the operation, which is known as Merck Research Laboratories (back story). As part of the changes, various senior management roles...Show More Summary
Avoiding Tort Hell? Pfizer Gets A Chance To Overturn Generic Injury Ruling
Earlier this year, the Alabama Supreme Court issued a highly contentious ruling that Pfizer can be sued by a man who claimed he was injured by a generic version of its Reglan heartburn medicine, because the brand-name drugmaker purportedly failed to warn his physician about the risks. Show More Summary
Access To The Morning After Pill Remains An Issue: Baruch Explains
Earlier this week, the Obama administration gave up its fight to block over-the-counter access to the newer, more popular version of the morning after pill called Plan B One-Step to girls or women (back story). The move largely ends a highly-charged, decade-long controversy over access to emergency contraception. Show More Summary
Compounding Problems: Big Insurer Ends Coverage For Compounded Meds
In the latest fallout from the compounding pharmacy scandal, Harvard Pilgrim Health Care, which is one of the largest insurers in New England, has decided to end coverage of specialty medications due to safety and cost concerns, The Boston Globe writes. Show More Summary
Pharmalot... Pharmalittle... The Weekend Nears
And so, another working week is about to draw to a close. One, two, three - hooray... This is as you know, our treasured signal to daydream about weekend plans. Once again, our agenda is modest. We plan to engage our short people in various activities, pull a few weeds and catch up on some reading. Show More Summary
Supreme Court Rules Human Genes Cannot Be Patented, But...
In a unanimous decision with important implications for biomedical research, the US Supreme Court has invalidated two patents held by Myriad Genetics that form the basis of a widely used genetic test for breast and ovarian cancers. But...Show More Summary
Why Do Most Americans Avoid Clinical Trials?
Despite increasing clamoring for new treatments, drugmakers regularly complain that enticing people in the US to enroll in clinical trials is not particularly easy. Often, the reasons given include a large percentage of the population...Show More Summary
Prevention In A Pill: Gilead Med Lowers HIV Risk In Injectable Drug Users
Less than a year after the FDA endorsed the notion of using medications to prevent HIV, a new study has found using the Viread pill sold by Gilead Sciences reduced the risk that addicts who inject drugs by nearly half. The findings are...Show More Summary
Pharmalot... Pharmalittle... Good Morning
Good morning, folks. Time to start another busy day, yes? And what better way to do so than with a jaunt to the schoolhouses with a cup of stimulation in hand? We are back, now, though and ready to engage in another round of interesting...Show More Summary
Another Glaxo Scandal In China: Bribing Doctors For Prescribing?
For the second time this month, GlaxoSmithKline is embroiled in scandal in China. The drugmaker is investigating allegations that its sales staff there was involved in bribing doctors to prescribe drugs, sometimes on an off-label basis,...Show More Summary
Tarnished Image? Psychiatrists Square Off Over A Nemeroff Lecture
For the second time in little more than a year, Charles Nemeroff is the subject of protest by other psychiatrists. The latest instance involves an invitation by the Institute of Psychiatry, the leading center in the UK for psychiatric...Show More Summary